Table 2

Ethnic differences in diarrheal side effects in respondents switching from BID SGCs to BID tablets

BID Respondents (n = 332)
 White (n = 136)
 Black (n = 123)
 Hispanic (n = 67)
Relative Risk (Tablets vs. SGCs)
Antidiarrheal use (more than "rarely use")
 0.73*
 0.72*
 0.95
 0.65
Diarrhea frequency 3+ per week
 0.60*
 0.68*
 0.52*
 0.39*
Respondent self-defined "severe" diarrhea
 0.28*
 0.47*
 0.13*
 0.17*
Proportion of respondents (Tablets vs. SGCs)
Respondent self-defined "severe" diarrhea
 3.3% vs. 11.7%*
 7% vs. 15%*
 1% vs. 8%*
 2% vs. 12%*

* p < 0.05

Schrader et al. AIDS Research and Therapy 2008 5:21   doi:10.1186/1742-6405-5-21
Open Data